On March 23, 2010, the Biologics Price Competition and Innovation Act (BPCIA) was signed into law in the US. Similar to the Hatch-Waxman Act, the BPCIA was intended to create incentives for the manufacture of highly similar biological products (or biosimilars) by creating an abbreviated regulatory approval process and marketing exclusivities for the first interchangeable product. Although biological drug products (or biologics) represented five of the top 10 selling drugs in the United States in 2012, with combined sales over $18.6 billion,1 there has not been an application for a biosimilar in the three and a half years since the BPCIA has been enacted. This raises the question whether the incentives for filing an application for a biosimilar are outweighed by the uncertainties in the approval process. Ha Kung Wong and Melissa Gibson discuss how these uncertainties and the incentives provided for biosimilars might impact the development of biologics into the future.
Related Services
Related Insights
The FDA Approves Zarxio® Opening the Door to the U.S. Biosimilars Market
The FDA Approves Zarxio® Opening the Door to the U.S. Biosimilars Market
March 11, 2015
5min
New Legislation Requires Certain Patent Information to Be Published in FDA Purple Book for Biological Products
New Legislation Requires Certain Patent Information to Be Published in FDA Purple Book for Biological Products
June 15, 2021
3min
Legal Experts Weigh in on BPCIA Severability
Legal Experts Weigh in on BPCIA Severability
October 22, 2020
1min
Events
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
April 25 - 26, 2024 New York, NY - American Conference Institute
Michael Joblove and Nina Greene to Speak at IFA Legal Symposium
Michael Joblove and Nina Greene to Speak at IFA Legal Symposium
May 05 - 07, 2024 Washington, DC
Nonprofits and Artificial Intelligence
Nonprofits and Artificial Intelligence
May 07, 2024 Washington, DC - Volunteers of America 2024 National Conference
Recent News
Venable Pro Bono Team Achieves Prisoner Release Under DC's Incarceration Reduction Amendment Act
Venable Pro Bono Team Achieves Prisoner Release Under DC's Incarceration Reduction Amendment Act
April 23, 2024
5min
American University Washington College of Law Alumni Association to Present Claudia Lewis with the Joseph H. Hairston Award on April 20
American University Washington College of Law Alumni Association to Present Claudia Lewis with the Joseph H. Hairston Award on April 20
April 19, 2024
1min
WAVe Presents: A Supreme Court Outlook and the Legacy of Ruth Bader Ginsburg
WAVe Presents: A Supreme Court Outlook and the Legacy of Ruth Bader Ginsburg
April 19, 2024
4min